<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Ariad Pharmaceuticals Edging Toward Becoming a Commercial Cancer Drug Company</title>
	<atom:link href="http://www.xconomy.com/boston/2008/09/02/ariad-pharmaceuticals-edging-toward-becoming-a-commercial-cancer-drug-company/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2008/09/02/ariad-pharmaceuticals-edging-toward-becoming-a-commercial-cancer-drug-company/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sun, 22 Nov 2009 23:52:13 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: david stamm</title>
		<link>http://www.xconomy.com/boston/2008/09/02/ariad-pharmaceuticals-edging-toward-becoming-a-commercial-cancer-drug-company/comment-page-1/#comment-27464</link>
		<dc:creator>david stamm</dc:creator>
		<pubDate>Thu, 04 Sep 2008 00:29:31 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=4571#comment-27464</guid>
		<description>There has not been anything new in many years for the treatment of sarcoma.  This drug has already shown efficacy in early trials and should be a blockbuster after final stage testing is completed.  Only the beginning for this drug which has numerous other applications.  Go ariad.</description>
		<content:encoded><![CDATA[<p>There has not been anything new in many years for the treatment of sarcoma.  This drug has already shown efficacy in early trials and should be a blockbuster after final stage testing is completed.  Only the beginning for this drug which has numerous other applications.  Go ariad.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Deformilus</title>
		<link>http://www.xconomy.com/boston/2008/09/02/ariad-pharmaceuticals-edging-toward-becoming-a-commercial-cancer-drug-company/comment-page-1/#comment-27409</link>
		<dc:creator>Deformilus</dc:creator>
		<pubDate>Wed, 03 Sep 2008 14:14:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=4571#comment-27409</guid>
		<description>Ariad is a joke and you are too for publishing such a puff piece on the company. The company never hits its deadlines and spends money like it is already a large pharmaceutical company.</description>
		<content:encoded><![CDATA[<p>Ariad is a joke and you are too for publishing such a puff piece on the company. The company never hits its deadlines and spends money like it is already a large pharmaceutical company.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Greg James</title>
		<link>http://www.xconomy.com/boston/2008/09/02/ariad-pharmaceuticals-edging-toward-becoming-a-commercial-cancer-drug-company/comment-page-1/#comment-27318</link>
		<dc:creator>Greg James</dc:creator>
		<pubDate>Tue, 02 Sep 2008 13:03:43 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=4571#comment-27318</guid>
		<description>Did you ask Dr. Berger why Wall Street doesn&#039;t believe a word he says?  It&#039;s called &quot;incompetence&quot;.</description>
		<content:encoded><![CDATA[<p>Did you ask Dr. Berger why Wall Street doesn&#8217;t believe a word he says?  It&#8217;s called &#8220;incompetence&#8221;.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
